The therapy-induced senescence-associated secretory phenotype and epithelial-mesenchymal transition Axis in ovarian cancer: molecular mechanisms and therapeutic opportunities

Expert Opinion on Therapeutic Targets · Published 2026-07-30 · DOI 10.1080/14728222.2026.2709798

Authors (4)

Ruiqi Wang, Dongsheng Shang, Zhigang Tu, Hanqing Liu

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Citation

Wang, R., Shang, D., Tu, Z., et al. (2026). The therapy-induced senescence-associated secretory phenotype and epithelial-mesenchymal transition Axis in ovarian cancer: molecular mechanisms and therapeutic opportunities. Expert Opinion on Therapeutic Targets. https://doi.org/10.1080/14728222.2026.2709798

Related articles

• Persistent accumulation of therapy-induced senescent cells: an obstacle to long-term cancer treatment efficacy · International Journal of Oral Science · 2025 · Cites or is cited by this article
• Inhibition of Interleukin-8/C-X-C Chemokine Receptor 2 Signaling Axis Prevents Tumor Growth and Metastasis in Triple-Negative Breast Cancer Cells · PHARMACOLOGY · 2025 · Cites or is cited by this article
• Advancements in the molecular understanding of major depressive disorder uncovering novel targets with therapeutic promise: focus on recurrence of illness · Expert Opinion on Therapeutic Targets · 2025 · Same journal
• Modulating tonic NMDA receptor currents: mechanistic insights into ketamine, esketamine, and dextromethorphan for major depressive disorder and implications for the discovery and development of investigational agents · Expert Opinion on Therapeutic Targets · 2026 · Same journal
• Molecular targets in gastric cancer for nanomedicine therapeutics: mechanistic insights and translational progress · Expert Opinion on Therapeutic Targets · 2026 · Same journal
• AQP7 suppresses cell stemness and metastasis by targeting Wnt signaling in basal-like breast cancer · Expert Opinion on Therapeutic Targets · 2026 · Same journal
• CDK7 as a New therapeutic target in pancreatic and lung cancer: current evidence and future perspectives · Expert Opinion on Therapeutic Targets · 2025 · Same journal
• Advances in CGRP therapeutic targets for migraine: where do we stand 5 years later? · Expert Opinion on Therapeutic Targets · 2026 · Same journal
• Transient receptor potential (TRP) channels: an emerging therapeutic target for the treatment of cardiac hypertrophy · Expert Opinion on Therapeutic Targets · 2026 · Same journal
• Lipopolysaccharide-targeting treatments for multidrug-resistant Pseudomonas aeruginosa · Expert Opinion on Therapeutic Targets · 2026 · Same journal